Literature DB >> 7806021

Presence and further development of retinal dysfunction after 3-year follow up in IDDM patients without angiographically documented vasculopathy.

M A Di Leo1, S Caputo, B Falsini, V Porciatti, A V Greco, G Ghirlanda.   

Abstract

Abnormalities in neuroretinal function may play a role in the development of diabetic retinopathy. The natural course of diabetic retinal dysfunction in a group of subjects with insulin-dependent diabetes mellitus and with no apparent microvascular alterations in the retina was followed-up with fluorescein angiography and a sensitive electrophysiological technique, i.e., steady-state focal electroretinogram at the macula, for 3 years. Before the beginning and throughout our study, strict glycaemic control was maintained by three or four daily insulin injections under careful monitoring. Analysis of macular electroretinogram provided information from different neural layers. At the first examination, functional activities of postreceptoral neurons were significantly decreased with respect to those of age-matched control subjects. Diabetic patients showed a functional loss of both ganglion cell (0.53 +/- 0.09 vs 0.42 +/- 0.11 microV; t = 5; p = 0.0001) and preganglion cell (0.51 +/- 0.13 vs 0.42 +/- 0.14 microV; t = 2.8; p = 0.007) layers. Diabetes did not alter photoreceptor activity. After 3 years, dysfunction was significantly greater in the preganglion cell layer (0.28 +/- 0.11 microV; t = 6.3; p = 0.0001). Although in some patients further impairment of ganglion cell function was shown, no significant difference was found in 3 years. Photoreceptor function remained unaltered. No vascular abnormalities in the retina were noted after 3 years in this group of patients. Metabolic control was not correlated to functional changes. Our findings suggest that the middle retinal layer is the most sensitive physiological locus of progressive diabetes-induced dysfunction in the absence of angiographically documented abnormalities.

Entities:  

Mesh:

Year:  1994        PMID: 7806021     DOI: 10.1007/bf00400947

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  51 in total

1.  Studies of retinal vascular patterns. I. Normal architecture.

Authors:  T KUWABARA; D G COGAN
Journal:  Arch Ophthalmol       Date:  1960-12

2.  Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat.

Authors:  A A Sima; W X Zhang; P V Cherian; S Chakrabarti
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

3.  Diabetic retinopathy viewed as a neurosensory disorder.

Authors:  G H Bresnick
Journal:  Arch Ophthalmol       Date:  1986-07

4.  Shall we count numbers of eyes or numbers of subjects?

Authors:  F Ederer
Journal:  Arch Ophthalmol       Date:  1973-01

5.  Human pattern-evoked electroretinogram.

Authors:  R F Hess; C L Baker
Journal:  J Neurophysiol       Date:  1984-05       Impact factor: 2.714

6.  Statistical analysis of multi-eye data in ophthalmic research.

Authors:  W A Ray; D M O'Day
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-08       Impact factor: 4.799

Review 7.  The clinical utility of the foveal electroretinogram: a review.

Authors:  W R Biersdorf
Journal:  Doc Ophthalmol       Date:  1989-12       Impact factor: 2.379

8.  Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM.

Authors:  G Ghirlanda; M A Di Leo; S Caputo; B Falsini; V Porciatti; G Marietti; A V Greco
Journal:  Diabetes       Date:  1991-09       Impact factor: 9.461

9.  A comparison of oscillatory potential and pattern electroretinogram measures in diabetic retinopathy.

Authors:  S G Coupland
Journal:  Doc Ophthalmol       Date:  1987-06       Impact factor: 2.379

10.  Early diagnosis of retinal changes in diabetes: a comparison between electroretinography and retinal biomicroscopy.

Authors:  P Wanger; H E Persson
Journal:  Acta Ophthalmol (Copenh)       Date:  1985-12
View more
  25 in total

Review 1.  Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms.

Authors:  C Hernández; A Simó-Servat; P Bogdanov; R Simó
Journal:  J Endocrinol Invest       Date:  2017-03-29       Impact factor: 4.256

Review 2.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

Review 3.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

4.  Glucosamine induces REDD1 to suppress insulin action in retinal Müller cells.

Authors:  Joshua A Moore; William P Miller; Michael D Dennis
Journal:  Cell Signal       Date:  2016-02-04       Impact factor: 4.315

5.  Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.

Authors:  M Mizutani; T S Kern; M Lorenzi
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

Review 6.  Diabetic retinal neurodegeneration as a form of diabetic retinopathy.

Authors:  Deepak Soni; Pradeep Sagar; Brijesh Takkar
Journal:  Int Ophthalmol       Date:  2021-05-06       Impact factor: 2.031

7.  Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy.

Authors:  Jan J Blom; Thomas J Giove; Tara L Favazza; James D Akula; William D Eldred
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-12

8.  Multifocal electroretinogram in diabetic subjects.

Authors:  Mona Abdelkader
Journal:  Saudi J Ophthalmol       Date:  2012-03-17

9.  The PERG in diabetic glaucoma suspects with no evidence of retinopathy.

Authors:  Lori M Ventura; Iuri Golubev; William J Feuer; Vittorio Porciatti
Journal:  J Glaucoma       Date:  2010 Apr-May       Impact factor: 2.503

10.  Increased neuronal nitric oxide synthase activity in retinal neurons in early diabetic retinopathy.

Authors:  Thomas J Giove; Monika M Deshpande; Christine S Gagen; William D Eldred
Journal:  Mol Vis       Date:  2009-11-09       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.